Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The charity has provided £126K of funding for one 3-year clinical research fellowship starting in January 2020.

Research into treatment and prevention

The Masonic Charitable Foundation awards research grants in recognition of the increasing need for improved treatments and prevention as our population ages.

Stroke and dementia are the two leading causes of neurological disability in the developed world and are the most costly in terms of health and social care. Reducing this burden requires more effective prevention, which is likely to be best achieved by studying both conditions in parallel.

The Centre for the Prevention of Stroke and Dementia (CPSD) has published over 400 research papers since 2000, and received the Queen’s Anniversary Prize for Higher Education in 2014 in recognition of impact on healthcare. It focuses mainly on clinical research with patients. By joining up NHS clinical care and research in the university we are able to provide answers to those questions that are of most immediate importance to patients, their families, and their clinicians.

CPSD is now housed in the new Wolfson Building on the John Radcliffe site, which provides the opportunity to expand research and to introduce new DPhil studentships. CPSD has an excellent track record of training research fellows, with over 30 successful DPhil or equivalent students over the last 15 years. DPhil projects usually involve one of CPSD's four main programmes to improve diagnosis, prognostication and targeting of treatment to prevent stroke and vascular dementia.


Similar stories

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Unique study of vascular disease reaches 20th anniversary

The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.

Sir Roger Bannister Prize Winners 2022

Congratulations to Alexander Hayes and Lily Watson for their success in this year's competition.

NDCN Thomas Willis Day Prize Winners

Our annual Thomas Willis Day celebrates the work of our Department over the previous year.

New book on global anaesthesia

Hilary Edgcombe, with two colleagues in other centres, has co-edited a new Oxford Handbook addressing safe anaesthesia in resource-limited settings

Our researchers test ‘Viagra’ drug to prevent recurrent strokes

Researchers in our Centre for the Prevention of Stroke and Dementia have begun a clinical trial to assess whether the drug sildenafil could improve blood flow to the brain.